Philip Morris wins renewed FDA backing for IQOS, keeping its modified-risk claims alive as the company accelerates its shift beyond cigarettes.
Get a deeper insight into the potential performance of Philip Morris (PM) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Philip Morris International might have had a lacklustre 2026 so far, but it could well see a price uptick following its Q1 2026 results, providing a trading opportunity. Typically, the stock tends to react sharply on earnings releases, and my estimates indicate that the adjusted EPS could surprise upwards, which can be positive for price. Over the remainder of the year, though, PM's price prospects are limited, with fair valuations, but over the medium and long term, it's firmly supported by stock metrics.
PM's first-quarter results are likely to show revenue and earnings growth, supported by pricing discipline and strength in smoke-free products.
Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Philip Morris International (NYSE:PM) reports Q1 2026 earnings on April 22, before the market opens.
Analysts view a reported FDA delay as a negative for the tobacco giant.
Philip Morris (PM) could produce exceptional returns because of its solid growth attributes.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Ausdal Financial Partners Inc. lifted its holdings in shares of Philip Morris International Inc. (NYSE: PM) by 32.6% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,519 shares of the company's stock after buying an additional 4,306 shares during
Ameriprise Financial Inc. cut its holdings in shares of Philip Morris International Inc. (NYSE: PM) by 4.6% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,592,465 shares of the company's stock after selling 221,548 shares during the period.
FORA Capital LLC acquired a new position in Philip Morris International Inc. (NYSE: PM) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 29,998 shares of the company's stock, valued at approximately $4,866,000. Philip Morris International comprises approximately 0.9% of FORA